These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3517417)

  • 41. Vitamin D and 9-cis retinoic acid: an efficient partnership for the induction of myelomonocytic cell growth inhibition and differentiation.
    Marti J; Commes T; Defacque H; Sevilla C
    Leuk Res; 1997 Feb; 21(2):173-6. PubMed ID: 9112435
    [No Abstract]   [Full Text] [Related]  

  • 42. Homoharringtonine--perspectives on an active new natural product.
    O'Dwyer PJ; King SA; Hoth DF; Suffness M; Leyland-Jones B
    J Clin Oncol; 1986 Oct; 4(10):1563-8. PubMed ID: 3531426
    [No Abstract]   [Full Text] [Related]  

  • 43. Suppression of leukemic growth by HFDI and LAI-615.
    Wu KF; Song YH; Li HZ; Rao Q; Zhu YM
    Ann N Y Acad Sci; 1991; 628():153-5. PubMed ID: 2069295
    [No Abstract]   [Full Text] [Related]  

  • 44. Differentiation factors.
    Gabrilove JL
    Semin Oncol; 1986 Jun; 13(2):228-33. PubMed ID: 3520829
    [No Abstract]   [Full Text] [Related]  

  • 45. [Induction of leukemic cell differentiation].
    Hozumi M
    Nihon Naika Gakkai Zasshi; 1994 Aug; 83(8):1371-6. PubMed ID: 7983423
    [No Abstract]   [Full Text] [Related]  

  • 46. A quantitative approach to the design of antitumor drug dosage schedule via cell cycle kinetics and systems theory.
    Kim M; Woo KB; Perry S
    Ann Biomed Eng; 1977 Mar; 5(1):12-33. PubMed ID: 557938
    [No Abstract]   [Full Text] [Related]  

  • 47. Induction of erythroid differentiation in the human leukaemia cell line K562.
    Andersson LC; Jokinen M; Gahmberg CG
    Nature; 1979 Mar; 278(5702):364-5. PubMed ID: 570644
    [No Abstract]   [Full Text] [Related]  

  • 48. Antitumour activity and cell kinetic effects of pyrazofurin in vitro.
    Hill BT; Whelan RD
    Eur J Cancer (1965); 1980 Dec; 16(12):1633-8. PubMed ID: 7014229
    [No Abstract]   [Full Text] [Related]  

  • 49. A multipotential leukemia cell line (K-562) of human origin.
    Lozzio BB; Lozzio CB; Bamberger EG; Feliu AS
    Proc Soc Exp Biol Med; 1981 Apr; 166(4):546-50. PubMed ID: 7194480
    [No Abstract]   [Full Text] [Related]  

  • 50. Differentiation therapy forces cancer cells to mature.
    Reynolds T
    J Natl Cancer Inst; 1991 Sep; 83(17):1209-11. PubMed ID: 1870144
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment for pre-leukaemia?
    Lancet; 1984 Apr; 1(8383):943-4. PubMed ID: 6143875
    [No Abstract]   [Full Text] [Related]  

  • 52. Synchronising cell division before cytotoxic treatment.
    Hughes-Davies TH
    Lancet; 1968 Jan; 1(7532):52-3. PubMed ID: 4169107
    [No Abstract]   [Full Text] [Related]  

  • 53. Web alert. Cell differentiation cell multiplication.
    Pines J; Toldo L; Lafont F
    Curr Opin Cell Biol; 1999 Dec; 11(6):651-2. PubMed ID: 10681126
    [No Abstract]   [Full Text] [Related]  

  • 54. [Fundamentals of leukemia differentiation therapy].
    Hozumi M
    Rinsho Ketsueki; 1992 May; 33(5):561-72. PubMed ID: 1630006
    [No Abstract]   [Full Text] [Related]  

  • 55. Potential applications of cytodifferentiation therapy in hematologic malignancies.
    Breitman TR; Chen ZX; Takahashi N
    Semin Hematol; 1994 Oct; 31(4 Suppl 5):18-25. PubMed ID: 7831581
    [TBL] [Abstract][Full Text] [Related]  

  • 56. To overcome pharmacologic and cytokinetic resistance to cytarabine in the treatment of acute myelogenous leukemia by using recombinant interleukin-3?
    Brach MA; Henschler R; Mertelsmann R; Herrmann F
    Semin Hematol; 1991 Jul; 28(3 Suppl 4):39-43. PubMed ID: 1780751
    [No Abstract]   [Full Text] [Related]  

  • 57. [Cell differentiation induction therapy in leukemia].
    Tashima M; Sawada H; Okazaki T; Mochizuki T; Ishikura H; Izumi Y; Uchino H
    Nihon Rinsho; 1986 Feb; 44(2):388-94. PubMed ID: 3517417
    [No Abstract]   [Full Text] [Related]  

  • 58. [Induction of cellular differentiation in the treatment of acute leukemias: preliminary report of the use of low doses of cytosine arabinoside for the induction of remission].
    Marín-López A; Lobato-Mendizábal E; Munive-Ordóñez I; Ruiz-Argüelles GJ
    Rev Invest Clin; 1984; 36(3):247-51. PubMed ID: 6515157
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.